BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)

BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)

No trades
See on Supercharts
Market capitalization
‪52.38 M‬USD
−6.640USD
‪−232.49 M‬USD
‪36.12 M‬USD
‪60.58 M‬
Beta (1Y)
4.67

About BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)

CEO
Robert Erik Holmlin
Headquarters
San Diego
Employees (FY)
344
Founded
2003
ISIN
US09075F3055
FIGI
BBG00X9DNG99
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0A4K is 0.80 USD — it has decreased by 5.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) stocks are traded under the ticker 0A4K.
BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) has a max estimate of 11.00 USD and a min estimate of 3.00 USD.
0A4K earnings for the last quarter are −3.22 USD whereas the estimation was −0.97 USD which accounts for −232.07% surprise. Estimated earnings for the next quarter are −0.87 USD. See more details about BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) earnings.
BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) revenue for the last quarter amounts to ‪9.32 M‬ USD despite the estimated figure of ‪9.08 M‬ USD. In the next quarter revenue is expected to reach ‪10.55 M‬ USD.
Yes, you can track BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) financials in yearly and quarterly reports right on TradingView.
0A4K stock has fallen by 20.26% compared to the previous week, the month change is a 20.65% fall, over the last year BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) has showed a 90.99% decrease.
Like other stocks, 0A4K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
0A4K reached its all-time high on Feb 16, 2021 with the price of 155.30 USD, and its all-time low was 0.95 USD and was reached on Apr 2, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 344.00 employees. See our rating of the largest employees — is BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) EBITDA is ‪−116.79 M‬ USD, and current EBITDA margin is −348.10%. See more stats in BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT) financial statements.